Multicenter iTBS Neuromodulation for PTSD Treatment
RecruitingNCT06434766Phase: NAStarted 2024-10-30
Summary
The proposed study aims to evaluate the efficacy of intermittent theta-burst transcranial magnetic stimulation (iTBS) targeting primary motor cortex (M1) as adjunct treatment for PTSD patients. The pr
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Shanghai Mental Health CenterShanghai, Shanghai Municipality, China
First Affiliated Hospital of Anhui Medical UniversityHangzhou, Zhejiang, China
Second Affiliated Hospital Zhejiang University School of MedHangzhou, Zhejiang, China
The Affiliated Kangning Hospital of Ningbo UniversityNingbo, Zhejiang, China
Tongji Hospital of Tongji UniversityShanghai, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06434766